tiprankstipranks
Advertisement
Advertisement
Adma Biologics falls -19.9%
PremiumThe FlyAdma Biologics falls -19.9%
10d ago
Cantor downgrades Adma Biologics on lack of clarity post short report
Premium
The Fly
Cantor downgrades Adma Biologics on lack of clarity post short report
10d ago
Adma Biologics says Culper report contains ‘inaccurate statements’
Premium
The Fly
Adma Biologics says Culper report contains ‘inaccurate statements’
11d ago
Culper Research short Adma Biologics, says reported growth ‘a fiction’
PremiumThe FlyCulper Research short Adma Biologics, says reported growth ‘a fiction’
12d ago
ADMA Biologics Launches Major 2026 Capital Return Plan
Premium
Company Announcements
ADMA Biologics Launches Major 2026 Capital Return Plan
1M ago
Adma Biologics announces $125M accelerated share repurchase with JPMorgan
Premium
The Fly
Adma Biologics announces $125M accelerated share repurchase with JPMorgan
1M ago
ADMA Biologics Reports Strong Q3 2025 Financial Results
PremiumCompany AnnouncementsADMA Biologics Reports Strong Q3 2025 Financial Results
5M ago
Adma Biologics reports Q3 EPS 15c, consensus 16c
Premium
The Fly
Adma Biologics reports Q3 EPS 15c, consensus 16c
5M ago
Adma Biologics raises FY25 revenue view to at least $510M from at least $500M
Premium
The Fly
Adma Biologics raises FY25 revenue view to at least $510M from at least $500M
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100